(Q33474320)

English

Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

0 references

Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors (English)

1 reference

Europe PubMed Central

27 July 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

J A Wagner

1

1 reference

Europe PubMed Central

27 July 2017

E C Wright

2

1 reference

Europe PubMed Central

27 July 2017

M M Ennis

3

1 reference

Europe PubMed Central

27 July 2017

M Prince

4

1 reference

Europe PubMed Central

27 July 2017

J Kochan

5

1 reference

Europe PubMed Central

27 July 2017

D J R Nunez

6

1 reference

Europe PubMed Central

27 July 2017

B Schneider

7

1 reference

Europe PubMed Central

27 July 2017

M-D Wang

8

1 reference

Europe PubMed Central

27 July 2017

Y Chen

9

1 reference

Europe PubMed Central

27 July 2017

S Ghosh

10

1 reference

Europe PubMed Central

27 July 2017

B J Musser

11

1 reference

Europe PubMed Central

27 July 2017

M T Vassileva

12

1 reference

Europe PubMed Central

27 July 2017

language of work or name

0 references

publication date

24 June 2009

1 reference

Europe PubMed Central

27 July 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

27 July 2017

86

1 reference

Europe PubMed Central

27 July 2017

6

1 reference

Europe PubMed Central

27 July 2017

619-625

1 reference

Europe PubMed Central

27 July 2017

The Biomarkers Consortium: on the critical path of drug discovery.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Glitazones: clinical effects and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Adiponectin and adiponectin receptors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Adiponectin is independently associated with glycosylated haemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Tesaglitazar, as add-on therapy to sulphonylurea, dose-dependently improves glucose and lipid abnormalities in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

A dual PPAR alpha/gamma agonist increases adiponectin and improves plasma lipid profiles in healthy subjects.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Early clinical development of pharmaceuticals for type 2 diabetes mellitus: from preclinical models to human investigation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

21 January 2018

Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and classification of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma adiponectin and hyperglycaemia in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.88

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2009.88

1 reference

Europe PubMed Central

27 July 2017

release_2x5tdcw6tjeejelofjpy76bt3e

1 reference

https://api.fatcat.wiki/v0/release/2x5tdcw6tjeejelofjpy76bt3e

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33474320&oldid=1835755932"